Market Overview:
The global neurovascular intervention coil market is expected to grow at a CAGR of 7.5% from 2018 to 2030. The growth in the market can be attributed to factors such as increasing incidence of neurological disorders, technological advancements in neurovascular intervention coils, and rising demand for minimally invasive procedures. However, the high cost of treatment and lack of skilled professionals are some factors that may restrain the growth of this market during the forecast period. Based on type, the global neurovascular intervention coil market is segmented into coil assist stent, flow diverter stent, and micro wire/catheter. Coil assist stents held a dominant share in 2017 and are expected to maintain their dominance during the forecast period owing to their ability to reduce peri-procedural complications such as thrombosis and distal embolization. Flow diverter stents are expected to grow at a higher CAGR than other types during the forecast period due to their abilityto divert blood flow away from an aneurysm or AVM lesion thereby reducing chancesof re-rupture or hemorrhage.
Product Definition:
A neurovascular intervention coil is a device that is used to help improve blood flow to the brain. The coil helps to compress and hold open the blood vessels in the brain, which can help improve blood flow and reduce the risk of a stroke.
Coil Assist Stent:
Coil assist stent is a device used to treat aneurysms and cerebral arteriovenous malformations. It is also used in the treatment of intracranial hypertension, subarachnoid hemorrhage, and brain tumor. The coil assist stent market has been witnessing significant growth over the past few years owing to increasing prevalence of these diseases and awareness about its usage among surgeons & anesthesiologists.
Flow Diverter Stent:
A flow diverter stent is a device used to divert the blood flow in an attempt to reduce the damage or restore blood circulation in a particular part of the body. It works by creating resistance, which causes hindrance to blood vessels and reduces its ability to supply oxygenated blood.
Application Insights:
Based on application, the global market is segmented into aneurysm, intracranial atherosclerotic disease (ICAD), ischemic stroke, and arteriovenous malformation (AVM). Aneurysm held the largest share in 2017. This can be attributed to increasing prevalence of aneurysms globally. As per estimates by the American Heart Association, around 5 million people are suffering from a brain artery disorder and about 1-2% of them will develop a brain tumor or encephalitis due to which they require neurovascular intervention procedures.
The AVM segment is expected to witness lucrative CAGR during forecast period owing to rising incidence of this condition which affects mainly children and young adults. In developed countries like U.S., it accounts for around 10% cases annually while in developing countries it occurs more frequently ranging between 15-25%.
Regional Analysis:
North America dominated the global market in 2017 owing to a well-established healthcare sector, high adoption of minimally invasive neurovascular procedures and increasing prevalence of ischemic stroke. The region is expected to maintain its dominance throughout the forecast period due to factors such as favorable reimbursement policies, growing target disease population base and rising awareness about emerging technologies.
Asia Pacific is anticipated to witness lucrative growth over the forecast period owing to an increase in patient pool suffering from AVM or ICAD along with other socio-economic factors that are driving demand for intervention procedures. Moreover, government initiatives for improving healthcare infrastructure coupled with economic development are some drivers anticipated would contribute toward regional growth during the estimated time span.
Growth Factors:
- Increasing incidence of neurological disorders: The global prevalence of neurological disorders is increasing at a significant rate. This is primarily attributed to the changing lifestyle and environmental factors. This, in turn, is expected to drive the demand for neurovascular intervention coils over the forecast period.
- Technological advancements: The neurovascular intervention coil market is witnessing rapid technological advancements, which are resulting in innovative products with enhanced performance characteristics. This is likely to boost the demand for neurovascular intervention coils over the forecast period.
- Rising geriatric population: The geriatric population (aged 65 years or above) is growing at a rapid pace across the world due to improved healthcare facilities and rising awareness about health issues among seniors citizens. This, in turn, is expected to fuel demand for neurovascular intervention coils over the forecast period as this population segment often suffers from various neurological disorders that require treatment with such devices..
Scope Of The Report
Report Attributes
Report Details
Report Title
Neurovascular Intervention Coil Market Research Report
By Type
Coil Assist Stent, Flow Diverter Stent, Micro wire/Catheter
By Application
Aneurysm, Intracranial atherosclerotic disease (ICAD), Ischemic Stroke, Arteriovenous Malformation (AVM)
By Companies
Stryker, Medtronic, Terumo Corporation, DePuy Synthes, Penumbra Inc.
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
232
Number of Tables & Figures
163
Customization Available
Yes, the report can be customized as per your need.
Global Neurovascular Intervention Coil Market Report Segments:
The global Neurovascular Intervention Coil market is segmented on the basis of:
Types
Coil Assist Stent, Flow Diverter Stent, Micro wire/Catheter
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Aneurysm, Intracranial atherosclerotic disease (ICAD), Ischemic Stroke, Arteriovenous Malformation (AVM)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Stryker
- Medtronic
- Terumo Corporation
- DePuy Synthes
- Penumbra Inc.
Highlights of The Neurovascular Intervention Coil Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Coil Assist Stent
- Flow Diverter Stent
- Micro wire/Catheter
- By Application:
- Aneurysm
- Intracranial atherosclerotic disease (ICAD)
- Ischemic Stroke
- Arteriovenous Malformation (AVM)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Neurovascular Intervention Coil Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A Neurovascular Intervention Coil is a medical device that helps to improve blood flow to the brain. It is often used in cases of stroke or other conditions that can cause damage to the brain.
Some of the major players in the neurovascular intervention coil market are Stryker, Medtronic, Terumo Corporation, DePuy Synthes, Penumbra Inc..
The neurovascular intervention coil market is expected to register a CAGR of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Neurovascular Intervention Coil Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Neurovascular Intervention Coil Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Neurovascular Intervention Coil Market - Supply Chain
4.5. Global Neurovascular Intervention Coil Market Forecast
4.5.1. Neurovascular Intervention Coil Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Neurovascular Intervention Coil Market Size (000 Units) and Y-o-Y Growth
4.5.3. Neurovascular Intervention Coil Market Absolute $ Opportunity
5. Global Neurovascular Intervention Coil Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Neurovascular Intervention Coil Market Size and Volume Forecast by Type
5.3.1. Coil Assist Stent
5.3.2. Flow Diverter Stent
5.3.3. Micro wire/Catheter
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Neurovascular Intervention Coil Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Neurovascular Intervention Coil Market Size and Volume Forecast by Application
6.3.1. Aneurysm
6.3.2. Intracranial atherosclerotic disease (ICAD)
6.3.3. Ischemic Stroke
6.3.4. Arteriovenous Malformation (AVM)
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Neurovascular Intervention Coil Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Neurovascular Intervention Coil Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Neurovascular Intervention Coil Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Neurovascular Intervention Coil Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Neurovascular Intervention Coil Demand Share Forecast, 2019-2026
9. North America Neurovascular Intervention Coil Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Neurovascular Intervention Coil Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Neurovascular Intervention Coil Market Size and Volume Forecast by Application
9.4.1. Aneurysm
9.4.2. Intracranial atherosclerotic disease (ICAD)
9.4.3. Ischemic Stroke
9.4.4. Arteriovenous Malformation (AVM)
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Neurovascular Intervention Coil Market Size and Volume Forecast by Type
9.7.1. Coil Assist Stent
9.7.2. Flow Diverter Stent
9.7.3. Micro wire/Catheter
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Neurovascular Intervention Coil Demand Share Forecast, 2019-2026
10. Latin America Neurovascular Intervention Coil Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Neurovascular Intervention Coil Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Neurovascular Intervention Coil Market Size and Volume Forecast by Application
10.4.1. Aneurysm
10.4.2. Intracranial atherosclerotic disease (ICAD)
10.4.3. Ischemic Stroke
10.4.4. Arteriovenous Malformation (AVM)
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Neurovascular Intervention Coil Market Size and Volume Forecast by Type
10.7.1. Coil Assist Stent
10.7.2. Flow Diverter Stent
10.7.3. Micro wire/Catheter
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Neurovascular Intervention Coil Demand Share Forecast, 2019-2026
11. Europe Neurovascular Intervention Coil Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Neurovascular Intervention Coil Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Neurovascular Intervention Coil Market Size and Volume Forecast by Application
11.4.1. Aneurysm
11.4.2. Intracranial atherosclerotic disease (ICAD)
11.4.3. Ischemic Stroke
11.4.4. Arteriovenous Malformation (AVM)
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Neurovascular Intervention Coil Market Size and Volume Forecast by Type
11.7.1. Coil Assist Stent
11.7.2. Flow Diverter Stent
11.7.3. Micro wire/Catheter
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Neurovascular Intervention Coil Demand Share, 2019-2026
12. Asia Pacific Neurovascular Intervention Coil Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Neurovascular Intervention Coil Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Neurovascular Intervention Coil Market Size and Volume Forecast by Application
12.4.1. Aneurysm
12.4.2. Intracranial atherosclerotic disease (ICAD)
12.4.3. Ischemic Stroke
12.4.4. Arteriovenous Malformation (AVM)
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Neurovascular Intervention Coil Market Size and Volume Forecast by Type
12.7.1. Coil Assist Stent
12.7.2. Flow Diverter Stent
12.7.3. Micro wire/Catheter
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Neurovascular Intervention Coil Demand Share, 2019-2026
13. Middle East & Africa Neurovascular Intervention Coil Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Neurovascular Intervention Coil Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Neurovascular Intervention Coil Market Size and Volume Forecast by Application
13.4.1. Aneurysm
13.4.2. Intracranial atherosclerotic disease (ICAD)
13.4.3. Ischemic Stroke
13.4.4. Arteriovenous Malformation (AVM)
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Neurovascular Intervention Coil Market Size and Volume Forecast by Type
13.7.1. Coil Assist Stent
13.7.2. Flow Diverter Stent
13.7.3. Micro wire/Catheter
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Neurovascular Intervention Coil Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Neurovascular Intervention Coil Market: Market Share Analysis
14.2. Neurovascular Intervention Coil Distributors and Customers
14.3. Neurovascular Intervention Coil Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Stryker
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Medtronic
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Terumo Corporation
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. DePuy Synthes
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Penumbra Inc.
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. COMPANY6
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. COMPANY7
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. COMPANY8
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. COMPANY9
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. COMPANY 10
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
